Eagle Asset Management Inc. Has $31.33 Million Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Eagle Asset Management Inc. lifted its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 0.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 434,514 shares of the company’s stock after buying an additional 3,227 shares during the quarter. Eagle Asset Management Inc. owned about 0.88% of Prestige Consumer Healthcare worth $31,328,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Boston Trust Walden Corp acquired a new stake in Prestige Consumer Healthcare in the third quarter worth $41,785,000. Ariel Investments LLC grew its holdings in Prestige Consumer Healthcare by 10.7% in the second quarter. Ariel Investments LLC now owns 2,835,203 shares of the company’s stock worth $195,204,000 after purchasing an additional 274,212 shares during the period. Allspring Global Investments Holdings LLC grew its holdings in Prestige Consumer Healthcare by 26.0% in the second quarter. Allspring Global Investments Holdings LLC now owns 1,320,125 shares of the company’s stock worth $90,891,000 after purchasing an additional 272,773 shares during the period. Victory Capital Management Inc. grew its holdings in Prestige Consumer Healthcare by 9.0% in the second quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company’s stock worth $142,827,000 after purchasing an additional 171,357 shares during the period. Finally, F M Investments LLC acquired a new stake in Prestige Consumer Healthcare in the second quarter worth $11,162,000. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have commented on PBH. DA Davidson restated a “buy” rating and issued a $95.00 price target on shares of Prestige Consumer Healthcare in a report on Monday, November 11th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $76.00 price objective (up from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. One investment analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, Prestige Consumer Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $83.67.

Prestige Consumer Healthcare Stock Up 0.8 %

Prestige Consumer Healthcare stock opened at $84.85 on Friday. Prestige Consumer Healthcare Inc. has a 1-year low of $56.61 and a 1-year high of $85.22. The firm has a market capitalization of $4.19 billion, a price-to-earnings ratio of 20.64, a price-to-earnings-growth ratio of 2.37 and a beta of 0.47. The firm’s fifty day moving average price is $74.13 and its two-hundred day moving average price is $70.57. The company has a current ratio of 3.56, a quick ratio of 2.10 and a debt-to-equity ratio of 0.61.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, November 7th. The company reported $1.09 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.09. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The company had revenue of $283.79 million for the quarter, compared to analyst estimates of $282.09 million. During the same period last year, the firm earned $1.07 earnings per share. The firm’s revenue was down .9% on a year-over-year basis. On average, equities research analysts predict that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider William P’pool sold 8,987 shares of Prestige Consumer Healthcare stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $81.85, for a total value of $735,585.95. Following the completion of the transaction, the insider now owns 20,058 shares in the company, valued at $1,641,747.30. This trade represents a 30.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Mary Beth Fritz sold 9,885 shares of Prestige Consumer Healthcare stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $81.97, for a total transaction of $810,273.45. Following the completion of the transaction, the senior vice president now owns 18,835 shares of the company’s stock, valued at $1,543,904.95. The trade was a 34.42 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 38,810 shares of company stock valued at $3,187,300. Company insiders own 1.60% of the company’s stock.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.